BridgeMD
New treatment option for Osteopenia
Official title Effects of High-Intensity Interval Training on Bone Health in Hong Kong Older Women
ClinicalTrials.gov ID: NCT06888544
What this study is testing
- What it's testing
- Osteoporosis is an age-related disease, characterized by a decreased bone mass and an increased risk of fragility fractures. Osteoporosis leads to increasing mortality, disabilities, morbidity of chronic pain, and the cost of health and social care, as well as decreasing the quality of life from reduced independence and hindered physical, mental, and social well-being.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 74, women only. Healthy volunteers may be eligible.
You may be able to join if
- 60 to 74 years at the start date of the project
- diagnosed with osteopenia by DXA scan screening with a BMD at the femoral neck or total hip or lumbar spine between -1 and -2.5 SD T-score below the...
- Passing the PAR-Q plus screening or with the physician's approval for readiness to participate in high-intensity exercise
- Above the average level of 2-mins stepping showing competent aerobic fitness
- No restriction on physical mobility
You likely can't join if
- Severe chronic disease restricting high-intensity exercise
- Having cognition impairment regarded by specialists
- checked through medical records at HA Go app platform in the past 6 months, have concurrent medical conditions (e.g., thyrotoxicosis or...
- any condition with osteoporosis, osteoporotic fractures
- current smoker
- alcohol 3 or more units per day.
See the full eligibility criteria
- 60 to 74 years at the start date of the project
- diagnosed with osteopenia by DXA scan screening with a BMD at the femoral neck or total hip or lumbar spine between -1 and -2.5 SD T-score below the average values
- Passing the PAR-Q plus screening or with the physician's approval for readiness to participate in high-intensity exercise
- Above the average level of 2-mins stepping showing competent aerobic fitness
- No restriction on physical mobility
- No cognitive impairment, as determined by the Chinese version of the Mini-Mental Status Examination (i.e., score \< 24)
- No previous substantial experiences in practicing HIIT. The written informed consent form will be collected from each participant
- Severe chronic disease restricting high-intensity exercise
- Having cognition impairment regarded by specialists
- checked through medical records at HA Go app platform in the past 6 months, have concurrent medical conditions (e.g., thyrotoxicosis or hyperparathyroidism, Paget's disease, renal disease, diabetes, knee or hip...
- any condition with osteoporosis, osteoporotic fractures
- current smoker
- alcohol 3 or more units per day.
The study team makes the final eligibility decision.
Where it's taking place
- China, Hong Kong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 60 years to 74 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include China, Hong Kong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.